Bristol Myers’ Mercier to Join Gilead as Chief Commercial Officer

Johanna Mercier has been appointed chief commercial officer of Gilead Sciences (NASDAQ: [[ticker:GILD]]). Mercier is joining the Foster City, CA, company from Bristol Myers Squibb (NYSE: [[ticker:BMY]]), where she was president and head of the company’s large markets division. Laura Hamill, Gilead’s executive vice president of worldwide commercial operations, is leaving the company. Mercier is slated to start at Gilead on July 1.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.